PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25277512-0	2014	An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.	2-chloro-N(6)cyclopentyladenosine	24-56	angiotensinogen	Rattus norvegicus	70-84	
25277512-1	2014	OBJECTIVES: The aim of this investigation was to study the underlying mechanism of an adenosine A1 receptor agonist 2-chloro-N6 cyclopentyladenosine (CCPA) inhibiting cardiomyocyte hypertrophy induced by angiotensin II (AngII).	2-chloro-N(6)cyclopentyladenosine	116-148	angiotensinogen	Rattus norvegicus	204-218	
25277512-1	2014	OBJECTIVES: The aim of this investigation was to study the underlying mechanism of an adenosine A1 receptor agonist 2-chloro-N6 cyclopentyladenosine (CCPA) inhibiting cardiomyocyte hypertrophy induced by angiotensin II (AngII).	2-chloro-N(6)cyclopentyladenosine	116-148	angiotensinogen	Rattus norvegicus	220-225	
25277512-1	2014	OBJECTIVES: The aim of this investigation was to study the underlying mechanism of an adenosine A1 receptor agonist 2-chloro-N6 cyclopentyladenosine (CCPA) inhibiting cardiomyocyte hypertrophy induced by angiotensin II (AngII).	2-chloro-N(6)cyclopentyladenosine	150-154	angiotensinogen	Rattus norvegicus	204-218	
25277512-1	2014	OBJECTIVES: The aim of this investigation was to study the underlying mechanism of an adenosine A1 receptor agonist 2-chloro-N6 cyclopentyladenosine (CCPA) inhibiting cardiomyocyte hypertrophy induced by angiotensin II (AngII).	2-chloro-N(6)cyclopentyladenosine	150-154	angiotensinogen	Rattus norvegicus	220-225	
25277512-13	2014	CONCLUSION: The A1 receptor agonist CCPA could significantly inhibit AngII-induced cardiomyocyte hypertrophy via the calcineurin signaling pathway.	2-chloro-N(6)cyclopentyladenosine	36-40	angiotensinogen	Rattus norvegicus	69-74